Given that HCK substrates are critically involved in cytoskeletal reorganization—mediating viral endocytosis—and in inflammatory signal transduction, including NF-κB pathway activation, HCK inhibition is likely to confer dual antiviral benefits: suppression of viral entry during the early stages of infection and attenuation of excessive host inflammatory responses in later phases. Here, HCK is linked to infection.